Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
740,370
-
Shares change
-
-648,456
-
Total reported value, excl. options
-
$1,080,988
-
Value change
-
-$948,266
-
Put/Call ratio
-
3.33%
-
Number of buys
-
4
-
Number of sells
-
-9
-
Price
-
$1.46
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q1 2025
28 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q1 2025.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 740,370 shares
of 66,587,586 outstanding shares and own 1.11% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (260,073 shares), GEODE CAPITAL MANAGEMENT, LLC (105,837 shares), EDGEWOOD MANAGEMENT LLC (100,000 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (44,682 shares), STATE STREET CORP (40,300 shares), RENAISSANCE TECHNOLOGIES LLC (38,596 shares), SeaCrest Wealth Management, LLC (34,954 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (27,681 shares), BlackRock, Inc. (23,184 shares), and CITADEL ADVISORS LLC (20,594 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.